Brian Kenneth Roberts - 16 Feb 2024 Form 4 Insider Report for Rezolute, Inc. (RZLT)

Role: Chief Medical Officer
Signature: /s/ Brian Kenneth Roberts
Issuer symbol: RZLT
Transactions as of: 16 Feb 2024
Net transactions value: +$9,142
Form type: 4
Filing time: 21 Feb 2024, 11:55:02 UTC
Previous filing: 25 Jan 2024
Next filing: 27 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RZLT	Common Shares	Purchase	$9,142	+7,000	+25%	$1.31	34,552	16 Feb 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.295 to $1.320, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Content

The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.295 to $1.320, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.